Back to JNJ
Aberdeen Group plc JNJ Position History
Johnson & Johnson • Healthcare
Quarters held
13
Latest value
$479.6M
Q3 2026
Peak value
$479.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $317.3M |
| Q3 2025 | $91K |
| Q3 2025 | $138.8M |
| Q4 2025 | $351.5M |
| Q4 2025 | $173.8M |
| Q1 2026 | $202.8M |
| Q1 2026 | $434.1M |
| Q2 2026 | $208.6M |
| Q2 2026 | $412.9M |
| Q3 2026 | $479.6M |
| Q3 2026 | $223.1M |
| Q3 2026 | $223.1M |
| Q3 2026 | $479.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $479.6M | 1.81M | — | — |
| Q3 2026 | $223.1M | 842.9K | — | — |
| Q3 2026 | $223.1M | 842.9K | — | — |
| Q3 2026 | $479.6M | 1.81M | — | — |
| Q2 2026 | $412.9M | 1.63M | — | — |
| Q2 2026 | $208.6M | 821.4K | — | — |
| Q1 2026 | $434.1M | 1.78M | — | — |
| Q1 2026 | $202.8M | 829.6K | — | — |
| Q4 2025 | $173.8M | 840.0K | — | — |
| Q4 2025 | $351.5M | 1.70M | — | — |
| Q3 2025 | $138.8M | 757.8K | — | — |
| Q3 2025 | $91K | 495 | — | — |
| Q3 2025 | $317.3M | 1.73M | — | — |